Cell targeting by the Staphylococcus aureus pore-forming toxins: it's not just about lipids
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Staphylococcus aureus employs numerous pore-forming cytotoxins to injure host immune cells and promote infection. Until recently, it was unclear how these cytotoxins targeted specific cell types for lysis. Membrane lipids were initially postulated to be cytotoxin receptor candidates. However, the cell-type specificity and species-dependent targeting of these toxins did not support lipids as sole receptors. The recent identification of proteinaceous receptors for several S. aureus cytotoxins now provides an explanation for the observed tropism. These findings also have important implications for the implementation of animal models to study S. aureus pathogenesis, and for the development of novel therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lina, G., Piemont, Y., Godail-Gamot, F., Bes, M., Peter, M.-O., Gauduchon, V., Vandenesch, F., & Etienne, J. (1999) · Clinical Infectious Diseases · doi:10.1086/313461 · Cited by 2,489 · cited 2×
“aureus clinical isolates have the α-hemolysin (hla) and γhemolysin (hlg) loci (24, 29), 87% of clinical isolates contain the lukED loci (30, 31), we have found the lukAB loci in 100% of the clinical isolates evaluated, and 5% of clinical isolates contain the pvl genes but 85% of MRSA isolates have pvl (32, 33).”
BackgroundGillet, Y., Issartel, B., Vanhems, P., Fournet, J.-C., Lina, G., Bes, M., Vandenesch, F., Piémont, Y., Brousse, N., Floret, D., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07877-7 · Cited by 1,514
Vandenesch, F., Lina, G., & Henry, T. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00012 · Cited by 405
Diep, B. A., Chan, L., Tattevin, P., Kajikawa, O., Martin, T. R., Basuino, L., Mai, T. T., Marbach, H., Braughton, K. R., Whitney, A. R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912403107 · Cited by 347
Kennedy, A. D., Wardenburg, J. B., Gardner, D. J., Long, D., Whitney, A. R., Braughton, K. R., Schneewind, O., & DeLeo, F. R. (2010) · The Journal of Infectious Diseases · doi:10.1086/656043 · Cited by 335 · cited 1×
“For example, the murine models developed to study α-hemolysin in vivo have proved to be highly informative for elucidating this toxin’s contribution to infection, revealing that α-hemolysin contributes to pneumonia, sepsis, and dermonecrosis in mice (64, 65).”
BackgroundListeriolysin O allows Listeria monocytogenes replication in macrophage vacuoles
Birmingham, C. L., Canadien, V., Kaniuk, N. A., Steinberg, B. E., Higgins, D. E., & Brumell, J. H. (2008) · Nature · doi:10.1038/nature06479 · Cited by 330 · cited 2×
“It is also generally accepted that this large family of toxins, which includes LLO, streptolysin O (SLO) produced by group A streptococci, pneumolysin produced by Streptococcus pneumoniae, and perfringolysin O (PLO) produced by Clostridium perfringens, utilize cholesterol as a receptor (8).”
BackgroundCCR5 is a receptor for Staphylococcus aureus leukotoxin ED
Alonzo III, F., Kozhaya, L., Rawlings, S. A., Reyes-Robles, T., DuMont, A. L., Myszka, D. G., Landau, N. R., Unutmaz, D., & Torres, V. J. (2013) · Nature · doi:10.1038/nature11724 · Cited by 291
Self-citationWardenburg, J. B., Palazzolo‐Ballance, A. M., Otto, M., Schneewind, O., & DeLeo, F. R. (2008) · The Journal of Infectious Diseases · doi:10.1086/592053 · Cited by 236
DuMont, A. L., Yoong, P., Day, C. J., Alonzo, F., McDonald, W. H., Jennings, M. P., & Torres, V. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305121110 · Cited by 216 · cited 10×
“aureus (59), it is unclear how LukAB promotes bacterial growth in the kidney, as murine PMNs are highly resistant to LukAB-mediated killing (47, 60).”
BackgroundInfluentialAlonzo III, F., Benson, M. A., Chen, J., Novick, R. P., Shopsin, B., & Torres, V. J. (2012) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07942.x · Cited by 155
Self-citation
Cited by
Pore-forming toxins: ancient, but never really out of fashion
Peraro, M. D., & van der Goot, F. G. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2015.3 · Cited by 788
Plant Natural Products Targeting Bacterial Virulence Factors
Silva, L. N., Zimmer, K. R., Macedo, A. J., & Trentin, D. S. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00184 · Cited by 504
Toxin-Induced Necroptosis Is a Major Mechanism of Staphylococcus aureus Lung Damage
Kitur, K., Parker, D., Nieto, P., Ahn, D. S., Cohen, T. S., Chung, S., Wachtel, S., Bueno, S., & Prince, A. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004820 · Cited by 263
Spaan, A. N., Vrieling, M., Wallet, P., Badiou, C., Reyes-Robles, T., Ohneck, E. A., Benito, Y., de Haas, C. J. C., Day, C. J., Jennings, M. P., et al. (2014) · Nature Communications · doi:10.1038/ncomms6438 · Cited by 166
Self-citationStaphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes
Spaan, A. N., Reyes-Robles, T., Badiou, C., Cochet, S., Boguslawski, K. M., Yoong, P., Day, C. J., de Haas, C. J. C., van Kessel, K. P. M., Vandenesch, F., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.08.001 · Cited by 114
“Several of the S. aureus leukocidins exhibit species specificity, which render them highly active against human cells, but not murine cells (DuMont and Torres, 2014).”
BackgroundSelf-citation
Metadata
- Authors
- DuMont, A. L., & Torres, V. J.
- Venue
- Trends in Microbiology
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 22
- Issue
- 1
- Pages
- 21-27
- ISSN
- 0966-842X (ISSN-L)
- OpenAlex
- W2095304931
- Cited by
- 111
- References
- 11
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cell targeting by the Staphylococcus aureus pore-forming toxins: it's not just about lipids. https://app.cochat.ai/papers/10.1016/j.tim.2013.10.004
- The paper
- DuMont, A. L., & Torres, V. J. (2014). Cell targeting by the Staphylococcus aureus pore-forming toxins: it's not just about lipids. Trends in Microbiology. https://doi.org/10.1016/j.tim.2013.10.004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.